Anti-HSV1 ICP8 Major DNA binding protein antibody [11E2]
5
(1 Review)
|
(54 Publications)
Mouse Monoclonal DNBI antibody. Suitable for WB, IP, ICC/IF and reacts with Herpes simplex virus samples. Cited in 54 publications.
View Alternative Names
ICP8, UL29, DBP, Major DNA-binding protein
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-HSV1 ICP8 Major DNA binding protein antibody [11E2] (AB20194)
Immunofluorescence analysis of HeLa cells transfected with pTF3 and pRF, staining HSV1 ICP8 Major DNA binding protein with ab20194.
Cells were fixed in paraformaldehyde for 10 min and then permeabilized with 0.5% Triton X-100 for 30 min. The cells were blocked with 4% BSA + 0.2% Tween for 30 min before incubation for 1 hour at RT with primary antibody (1/200 diluted in PBS-T). An AlexaFluor®488-conjugated donkey anti-mouse IgG (1/2000) was used as the secondary antibody.
Image from Alazard-Dany N et al., PLoS Pathog. 2009 Mar;5(3):e1000340. Epub 2009 Mar 13. Fig 5.; doi:10.1371/journal.ppat.1000340; March 13, 2009, PLoS Pathog 5(3): e1000340.
- ICC/IF
AbReview39583****
Immunocytochemistry/ Immunofluorescence - Anti-HSV1 ICP8 Major DNA binding protein antibody [11E2] (AB20194)
ab20194 staining HSV1 ICP8 Major DNA binding protein in Human U2OS cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.5% Triton X-100 and blocked with 5% serum for 20 minutes at 22°C. Samples were incubated with primary antibody (1/200) for 1 hour at 22°C. An Alexa Fluor® 488-conjugated Goat anti-mouse IgG polyclonal (1/1000) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-HSV1 ICP8 Major DNA binding protein antibody [11E2] (AB20194)
Immunofluorescence analysis of cells infected with HSV1, staining HSV1 ICP8 Major DNA binding protein (purple) with ab20194, 7 (left) or 17 (right) hours after infection.
Cells were permeabilized in 0.1% Triton X-100 in PBS for 5 min at room temperature before blocking with blocking buffer (4% goat serum, 1% BSA in PBS-Tween [0.05%]) for 30 min at room temperature. Samples were incubated with primary antibody (1/1000) and a fluorescence conjugated anti-mouse IgG was used to detect staining.
Image from Ohta A et al., Virol J. 2011 Jul 26;8:365. Fig 5.; doi:10.1186/1743-422X-8-365; 26 July 2011, Virology Journal 2011, 8:365
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ICP8 serves to orchestrate virus replication by acting at the core of the viral replication complex. It operates predominantly as a monomer but can form homo-oligomers in the presence of DNA. ICP8 interaction with other viral replication proteins such as UL5 UL52 and UL8 highlights its role as a scaffolding protein within the replication complex. Through binding and restructuring DNA ICP8 ensures efficient replication fork progression and genomic stability during HSV1 replication.
Pathways
ICP8 integrates critically into the replication pathway of HSV1. The replication process begins with initiation transitions through elongation and concludes with termination. Proteins related to these processes include UL9 which interacts with ICP8 to facilitate unwinding of the viral DNA. Another protein the polymerase-accessory protein UL42 works closely with ICP8 during the elongation of DNA synthesis. Through these interactions ICP8 plays a critical role in the orchestration and assembly of the HSV1 genome replication machinery.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (54)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed40724934
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5313 PubMed40537528
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Methods & clinical development 33:101471 PubMed40454417
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 99:e0163824 PubMed39945537
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of microbiology (Seoul, Korea) 63:e.2409007 PubMed39895072
2025
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 16: PubMed39772124
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in microbiology 15:1411655 PubMed38915300
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 98:e0201523 PubMed38451083
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed37702383
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 19:e1011539 PubMed37486931
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com